Hexagon Capital Partners’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-5,959
Closed -$330K – 1461
2025
Q1
$330K Buy
5,959
+238
+4% +$12.9K 0.06% 143
2024
Q4
$276K Buy
5,721
+365
+7% +$18.6K 0.05% 166
2024
Q3
$309K Buy
5,356
+255
+5% +$13.8K 0.06% 149
2024
Q2
$248K Buy
5,101
+267
+6% +$12.9K 0.05% 169
2024
Q1
$235K Sell
4,834
-159
-3% -$7.76K 0.05% 181
2023
Q4
$248K Buy
4,993
+984
+25% +$48.1K 0.06% 164
2023
Q3
$215K Buy
4,009
+495
+14% +$26.4K 0.06% 163
2023
Q2
$189K Buy
3,514
+672
+24% +$36.2K 0.05% 171
2023
Q1
$155K Sell
2,842
-481
-14% -$23.4K 0.04% 189
2022
Q4
$161K Sell
3,323
-147
-4% -$6.45K 0.05% 176
2022
Q3
$132K Buy
3,470
+1,213
+54% +$54.1K 0.04% 200
2022
Q2
$113K Buy
2,257
+767
+51% +$40.7K 0.03% 249
2022
Q1
$76K Hold
1,490
– – 0.02% 310
2021
Q4
$75K Hold
1,490
– – 0.02% 307
2021
Q3
$72K Sell
1,490
-20
-1% -$1.02K 0.02% 299
2021
Q2
$80K Hold
1,510
– – 0.02% 273
2021
Q1
$74K Buy
1,510
+39
+3% +$1.87K 0.02% 268
2020
Q4
$71K Sell
1,471
-950
-39% -$46.9K 0.02% 236
2020
Q3
$112K Buy
+2,421
New +$125K 0.04% 166

Other funds holding SNY

Hexagon Capital Partners's SNY Position: Q2 2025 in Review

Hexagon Capital Partners sold out of Sanofi (SNY) in Q2 2025, closing a stake of 5,959 shares — an estimated $330K sold.

Hexagon Capital Partners first reported a position in SNY in Q3 2020 and held it in 19 quarters. The position peaked at $330K in Q1 2025. 731 funds tracked by Wall St. Rank hold SNY as of Q2 2025.

  • Hexagon Capital Partners reported no remaining Sanofi position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 5,959 Sanofi shares in Q2 2025, an estimated $330K.
  • Hexagon Capital Partners first reported a position in Sanofi in Q3 2020 and held it in 19 quarters.
  • Hexagon Capital Partners's Sanofi position peaked at $330K in Q1 2025.
  • 731 funds tracked by Wall St. Rank held Sanofi as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.